VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

Stock Comparison

EssilorLuxottica vs Stevanato Group S.p.A.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

EssilorLuxottica

EL · Euronext Paris

Market cap (USD)$94.1B
Gross margin (TTM)61.5%
Operating margin (TTM)12.4%
Net margin (TTM)8.5%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryFR
Data as of2026-01-11
Moat score
69/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into EssilorLuxottica's moat claims, evidence, and risks.

View EL analysis

Stevanato Group S.p.A.

STVN · New York Stock Exchange

Market cap (USD)$4.9B
Gross margin (TTM)29%
Operating margin (TTM)16.6%
Net margin (TTM)11.8%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryIT
Data as of2026-05-27
Moat score
61/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Stevanato Group S.p.A.'s moat claims, evidence, and risks.

View STVN analysis

Comparison highlights

  • Moat score gap: EssilorLuxottica leads (69 / 100 vs 61 / 100 for Stevanato Group S.p.A.).
  • Segment focus: EssilorLuxottica has 2 segments (52.7% in Direct to Consumer); Stevanato Group S.p.A. has 3 segments (47% in High-Value Solutions).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
  • Moat breadth: EssilorLuxottica has 5 moat types across 3 domains; Stevanato Group S.p.A. has 8 across 3.

Primary market context

EssilorLuxottica

Direct to Consumer

Market

Optical retail and e-commerce (prescription eyewear and sunglasses)

Geography

Global

Customer

Consumers (end-users)

Role

Omnichannel retailer + vertically integrated manufacturer/brand owner

Revenue share

52.7%

Stevanato Group S.p.A.

High-Value Solutions

Market

High-value primary packaging and integrated solutions for injectable drugs

Geography

Global

Customer

Pharmaceutical, biotechnology, and life sciences companies; fill-finish CMOs

Role

Primary packaging/component manufacturer (ready-to-use), plus supporting services

Revenue share

47%

Side-by-side metrics

EssilorLuxottica
Stevanato Group S.p.A.
Ticker / Exchange
EL - Euronext Paris
STVN - New York Stock Exchange
Market cap (USD)
$94.1B
$4.9B
Gross margin (TTM)
61.5%
29%
Operating margin (TTM)
12.4%
16.6%
Net margin (TTM)
8.5%
11.8%
Sector
Healthcare
Healthcare
Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
HQ country
FR
IT
Primary segment
Direct to Consumer
High-Value Solutions
Market structure
Competitive
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Strong
Moat score
69 / 100
61 / 100
Moat domains
Legal, Supply, Demand
Demand, Supply, Network
Last update
2026-01-11
2026-05-27

Moat coverage

Shared moat types

Brand Trust

EssilorLuxottica strengths

IP Choke PointDistribution ControlScale Economies Unit CostContractual Exclusivity

Stevanato Group S.p.A. strengths

Design In QualificationCapex Knowhow ScaleDe Facto StandardLong Term ContractsOperational ExcellenceService Field NetworkScope Economies

Segment mix

EssilorLuxottica segments

Full profile >

Professional Solutions

Oligopoly

47.3%

Direct to Consumer

Competitive

52.7%

Stevanato Group S.p.A. segments

Full profile >

High-Value Solutions

Oligopoly

47%

Other Containment and Delivery Solutions

Competitive

44%

Engineering

Competitive

9%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.